📊 ODYY Key Takeaways
Is Odyssey Health, Inc. (ODYY) a Good Investment?
Odyssey Health exhibits critical financial distress with zero revenue generation, negative stockholders' equity of -$10.6M, and ongoing cash burn of -$576.3K in free cash flow. The company's liquidity crisis (current ratio 0.06x) and inability to service debt (interest coverage -1.1x) present existential viability concerns. Without immediate operational turnaround and significant capital infusion, the company faces imminent insolvency.
Odyssey Health is pre-revenue with sustained losses, negative equity, and an extremely weak liquidity profile (current ratio ~0.06x) indicating acute going-concern risk. Interest coverage is negative and debt is meaningful relative to assets, suggesting reliance on external financing. Without a near-term revenue inflection or capital raise, dilution or insolvency risk dominates the fundamental outlook.
Why Buy Odyssey Health, Inc. Stock? ODYY Key Strengths
- Retains $616.3K in cash providing limited runway for operations or restructuring
- Relatively small asset base of $721.3K allows for potential strategic alternatives
- Operates in established medical device sector with addressable market opportunity
- Asset-light model with minimal capex requirements
- Operating expenses appear relatively contained vs. net loss drivers
- Cash comprises most of the asset base, offering some flexibility
ODYY Stock Risks: Odyssey Health, Inc. Investment Risks
- Zero revenue generation indicating non-operational business status
- Negative stockholders equity of -$10.6M representing technical insolvency
- Severe liquidity crisis with current ratio of 0.06x unable to cover short-term obligations
- Negative operating cash flow of -$568.3K with estimated 12-month cash runway remaining
- Interest coverage ratio of -1.1x indicates inability to service $2.0M long-term debt
- No insider activity over 90 days suggests absence of management confidence or initiative
- Going-concern risk from severe liquidity shortfall and negative equity
- High dilution/refinancing risk to sustain operations
- Debt burden with negative interest coverage amplifies financial stress
Key Metrics to Watch
- Achievement of revenue generation and operational restart timeline
- Monthly operating cash flow trends and cash depletion rate
- Debt restructuring or capital infusion announcements
- Stockholders equity recovery path and recapitalization milestones
- Operating cash burn (quarterly OCF)
- Current ratio and cash balance vs. near-term liabilities
Odyssey Health, Inc. (ODYY) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
ODYY Profit Margin, ROE & Profitability Analysis
ODYY vs Healthcare Sector: How Odyssey Health, Inc. Compares
How Odyssey Health, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Odyssey Health, Inc. Stock Overvalued? ODYY Valuation Analysis 2026
Based on fundamental analysis, Odyssey Health, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Odyssey Health, Inc. Balance Sheet: ODYY Debt, Cash & Liquidity
ODYY Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Odyssey Health, Inc.'s revenue has declined by 100% over the 5-year period, indicating business contraction. The most recent EPS of $-0.01 indicates the company is currently unprofitable.
ODYY Revenue Growth, EPS Growth & YoY Performance
ODYY Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2020 | N/A | -$62.8K | $0.00 |
| Q2 2020 | N/A | -$106.5K | $0.00 |
| Q1 2020 | N/A | -$69.5K | $0.00 |
| Q3 2019 | N/A | -$62.8K | $0.00 |
| Q2 2019 | N/A | -$106.5K | $0.00 |
| Q1 2019 | N/A | -$63.4K | $0.00 |
| Q3 2018 | N/A | -$73.6K | $0.00 |
| Q2 2018 | N/A | -$31.2K | $0.00 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Odyssey Health, Inc. Dividends, Buybacks & Capital Allocation
ODYY SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Odyssey Health, Inc. (CIK: 0001626644)
📋 Recent SEC Filings
❓ Frequently Asked Questions about ODYY
What is the AI rating for ODYY?
Odyssey Health, Inc. (ODYY) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 92% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are ODYY's key strengths?
Claude: Retains $616.3K in cash providing limited runway for operations or restructuring. Relatively small asset base of $721.3K allows for potential strategic alternatives. ChatGPT: Asset-light model with minimal capex requirements. Operating expenses appear relatively contained vs. net loss drivers.
What are the risks of investing in ODYY?
Claude: Zero revenue generation indicating non-operational business status. Negative stockholders equity of -$10.6M representing technical insolvency. ChatGPT: Going-concern risk from severe liquidity shortfall and negative equity. High dilution/refinancing risk to sustain operations.
What is ODYY's revenue and growth?
Odyssey Health, Inc. reported revenue of $0.0.
Does ODYY pay dividends?
Odyssey Health, Inc. does not currently pay dividends.
Where can I find ODYY SEC filings?
Official SEC filings for Odyssey Health, Inc. (CIK: 0001626644) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is ODYY's EPS?
Odyssey Health, Inc. has a diluted EPS of $-0.04.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is ODYY a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Odyssey Health, Inc. has a STRONG SELL rating with 92% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is ODYY stock overvalued or undervalued?
Valuation metrics for ODYY: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy ODYY stock in 2026?
Our dual AI analysis gives Odyssey Health, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is ODYY's free cash flow?
Odyssey Health, Inc.'s operating cash flow is $-568.3K, with capital expenditures of $8.0K.
How does ODYY compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio 0.06 (avg: 2).